Cargando…

A Rapid, Semi-Quantitative Assay to Screen for Modulators of Alpha-Synuclein Oligomerization Ex vivo

Alpha synuclein (αsyn) aggregates are associated with the pathogenesis of Parkinson's disease and others related disorders. Although modulation of αsyn aggregation is an attractive therapeutic target, new powerful methodologies are desperately needed to facilitate in vivo screening of novel the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delenclos, Marion, Trendafilova, Teodora, Jones, Daryl R., Moussaud, Simon, Baine, Ann-Marie, Yue, Mei, Hirst, Warren D., McLean, Pamela J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717311/ https://www.ncbi.nlm.nih.gov/pubmed/26834539 http://dx.doi.org/10.3389/fnins.2015.00511

Ejemplares similares

Investigation of Endocytic Pathways for the Internalization of Exosome-Associated Oligomeric Alpha-Synuclein
por: Delenclos, Marion, et al.
Publicado: (2017)

Alpha-synuclein and tau: teammates in neurodegeneration?
por: Moussaud, Simon, et al.
Publicado: (2014)

Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in Mice
por: Cai, Waijiao, et al.
Publicado: (2018)

Neonatal AAV delivery of alpha-synuclein induces pathology in the adult mouse brain
por: Delenclos, Marion, et al.
Publicado: (2017)

Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway
por: Park, Jae-Hyeon, et al.
Publicado: (2020)

Honokiol decreases alpha-synuclein mRNA levels and reveals novel targets for modulating alpha-synuclein expression
por: Fagen, Sara J., et al.
Publicado: (2023)

Microtubule Depolymerization Potentiates Alpha-Synuclein Oligomerization
por: Esteves, A. Raquel, et al.
Publicado: (2010)

Formation of Toxic Oligomeric α-Synuclein Species in Living Cells
por: Outeiro, Tiago Fleming, et al.
Publicado: (2008)

Correction: Formation of Toxic Oligomeric α-Synuclein Species in Living Cells
por: Outeiro, Tiago Fleming, et al.
Publicado: (2008)

Proaggregant nuclear factor(s) trigger rapid formation of α-synuclein aggregates in apoptotic neurons
por: Jiang, Peizhou, et al.
Publicado: (2016)

Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD
por: Esteves, A. R., et al.
Publicado: (2011)

Preanalytical Stability of CSF Total and Oligomeric Alpha-Synuclein
por: Abdi, Ilham Y., et al.
Publicado: (2021)

α-synuclein interacts with SOD1 and promotes its oligomerization
por: Helferich, Anika M., et al.
Publicado: (2015)

Alpha‐synuclein‐associated changes in PINK1‐PRKN‐mediated mitophagy are disease context dependent
por: Hou, Xu, et al.
Publicado: (2023)

Investigating the Pathogenic Interplay of Alpha-Synuclein, Tau, and Amyloid Beta in Lewy Body Dementia: Insights from Viral-Mediated Overexpression in Transgenic Mouse Models
por: Lim, Melina J., et al.
Publicado: (2023)

Antibodies against Alpha-Synuclein Reduce Oligomerization in Living Cells
por: Näsström, Thomas, et al.
Publicado: (2011)

Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson’s Disease
por: Vivacqua, Giorgio, et al.
Publicado: (2016)

Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease
por: Gallegos, Scarlet, et al.
Publicado: (2015)

The Golgi-localized, gamma ear-containing, ARF-binding (GGA) protein family alters alpha synuclein (α-syn) oligomerization and secretion
por: von Einem, Bjoern, et al.
Publicado: (2017)

In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis
por: Ouzounoglou, Eleftherios, et al.
Publicado: (2014)

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
por: Majbour, Nour K., et al.
Publicado: (2016)

Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation
por: Lázaro, Diana F., et al.
Publicado: (2014)

Alpha-synuclein Toxicity in the Early Secretory Pathway: How It Drives Neurodegeneration in Parkinsons Disease
por: Wang, Ting, et al.
Publicado: (2015)

Dopamine-Induced Conformational Changes in Alpha-Synuclein
por: Outeiro, Tiago F., et al.
Publicado: (2009)

The Role of Alpha-Synuclein Oligomerization and Aggregation in Cellular and Animal Models of Parkinson’s Disease
por: Wan, Oi Wan, et al.
Publicado: (2012)

Dataset of total, oligomeric alpha-synuclein and hemoglobin levels in plasma in Parkinson׳s disease
por: Emelyanov, A., et al.
Publicado: (2016)

How epigallocatechin gallate binds and assembles oligomeric forms of human alpha-synuclein
por: Andersen, Camilla B., et al.
Publicado: (2021)

Is Alpha-Synuclein Loss-of-Function a Contributor to Parkinsonian Pathology? Evidence from Non-human Primates
por: Collier, Timothy J., et al.
Publicado: (2016)

Direct detection of alpha synuclein oligomers in vivo
por: Dimant, Hemi, et al.
Publicado: (2013)

Exosomal cell-to-cell transmission of alpha synuclein oligomers
por: Danzer, Karin M, et al.
Publicado: (2012)

The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation
por: Lázaro, Diana F., et al.
Publicado: (2016)

Monitoring alpha‐synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: What you see is not always what you get
por: Frey, Bryan, et al.
Publicado: (2020)

Direct Visualization of CHIP-Mediated Degradation of Alpha-Synuclein In Vivo: Implications for PD Therapeutics
por: Dimant, Hemi, et al.
Publicado: (2014)

Single-molecule FRET studies on alpha-synuclein oligomerization of Parkinson’s disease genetically related mutants
por: Tosatto, Laura, et al.
Publicado: (2015)

Small Molecules Attenuate the Interplay between Conformational Fluctuations, Early Oligomerization and Amyloidosis of Alpha Synuclein
por: Ghosh, Sumanta, et al.
Publicado: (2018)

Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles
por: Doucet, Marika, et al.
Publicado: (2017)

Drug Targeting of α-Synuclein Oligomerization in Synucleinopathies
por: Outeiro, Tiago Fleming, et al.
Publicado: (2008)

Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays
por: Bellomo, Giovanni, et al.
Publicado: (2023)

Inhibition of Calpain Prevents Manganese-Induced Cell Injury and Alpha-Synuclein Oligomerization in Organotypic Brain Slice Cultures
por: Xu, Bin, et al.
Publicado: (2015)

Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease
por: Majbour, Nour K., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r225eca9l6m7anjvouc842n5nu